Inveready invests in tech and biotech companies through equity and hybrid debt / equity instruments.
Tech: we look for disruptive enabling technology solutions such as NLP, AI, Devops and other spaces. We have some success stories such as Indisys (Intel), Passwordbank (Symantec), 3Scale (RedHat), MasMovil (Ibercom), Agile (IPO).
Biotech: we look for pre-clinical stage drug discovery companies with a disruptive technology. We also invest in reprofilling, biotech enabling technologies and healthcare companies. Some of our succesful companies are: Palobiofarma and Ability Pharmaceuticals.
Inveready is one of the leading early-stage venture capital funds in Spain and a pan European hybrid quasi equity investor in small cap quoted companies
Inveready, through its seven funds, invests both Equity and Venture Debt in technology companies, with high growth potential and innovative business models. Inveready has more than 80 portfolio companies that are leaders in their respective markets. Inveready also invests in quoted continental European companies with hybrid quasi equity instruments through a dedicated fund
C/ Dels Cavallers 50
+34 93 180 72 60
C/ Serrano, 50, 1º Ext. Dcha.
+34 91 193 30 72
350 Townsend St. Suite 308A
San Francisco - CA 94107